What changed in this filing

/stocks — the workspaceLOADING

Item 7. Management’s Discussion and Analysis

2025-02-28 compared with 2024-02-29 · 226 added, 199 removed, 380 unchanged (53% of the section changed)

8 unchanged sentences

Advanced Materials & Catalysts :

We are a global supplier of finished silica catalyst, catalyst supports and functionalized silicas necessary to produce high performing plastics and to enable sustainable chemistry.

This segment includes our 50% interest in the Zeolyst Joint Venture, where we are a leading global supplier of zeolites used for catalysts that support the production of sustainable fuels, remove nitrogen oxides from diesel engine emissions and are broadly applied in refining and petrochemical processes.

We are a global supplier of finished silica catalyst, catalyst supports and functionalized silicas necessary to produce high performing plastics and to enable sustainable chemistry through our Advanced Silicas business .

This segment also includes our 50% interest in the Zeolyst Joint Venture, where we are a leading global supplier of specialty zeolites used in catalysts that supports the production of sustainable fuels, remove nitrogen oxides from diesel engine emissions and that are broadly applied in refining and petrochemical processes.

Table of Con ten ts

Effective November 28, 2023, the Company renamed the Catalyst Technologies segment to Advanced Materials & Catalysts.

Beginning with the year ended December 31, 2023, the segment results and disclosures included in the Company’s consolidated financial statements reflect the new segment name for all periods presented.

This change to the Company’s segment name does not change the Company’s consolidated balance sheets, statements of income or cash flows for the prior periods or the way the Company’s chief operating decision maker (“CODM”) evaluated the business.

In 2023, we served global customers across many end uses and, as of December 31, 2023, operated out of ten strategically located manufacturing facilities.

On December 14, 2020, we completed the sale of our Performance Materials business to Potters Buyer, LLC, an affiliate of The Jordan Company, L.P.

In 2024, we served global customers across many end uses and, as of December 31, 2024, operated out of ten strategically located owned manufacturing facilities.

Effective on August 1, 2021, we completed the sale of our Performance Chemicals business to Sparta Aggregator L.P., a partnership with Koch Minerals & Trading, LLC and Cerberus Capital Management, L.P.

The results of operations, financial condition, and cash flows for the Performance Materials and Performance Chemicals businesses are presented herein as discontinued operations for the 2022 and 2021 periods presented.

The results of operations, financial condition, and cash flows for the Performance Chemicals business are presented herein as discontinued operations for the 2022 period presented.

Refer to Note 4 of our consolidated financial statements for additional information.

3 unchanged sentences

We have no operations in Russia or Ukraine.

We had no sales to customers in Ukraine and Russia in December 31, 2023 and our sales to a customer in Russia were immaterial for the year ended December 31, 2022 and 2% for the year ended December 31, 2021.

We also did not make any purchases from suppliers in Russia or Ukraine.

We had no sales to customers or purchases from suppliers in Ukraine and Russia for the years ended December 31, 2024 and 2023.

Our sales to a customer in Russia were immaterial and we did not make any purchases from suppliers for the year ended December 31, 2022.

As Russia’s invasion of Ukraine continues to unfold, we will continue to monitor compliance with sanctions imposed by the U.S.

government and other countries.

We continue to monitor the developments in the Middle East.

Although the Company experienced shipment delays, the impact remained immaterial on our business.

We also continue to monitor the developments in the Middle East.

Although the Company experienced shipment delays during the year, the impact remained immaterial to our business.

Stock Repurchase Program

On April 27, 2022, the Board approved a stock repurchase program that authorized the Company to purchase up to $450.0 million of the Company’s common stock over the four-year period from the date of approval.

For the year ended December 31, 2024, the Company repurchased 552,081 shares on the open market at an average price of $9.05 per share, for a total of $5.0 million excluding brokerage commissions and accrued excise tax.

As of December 31, 2024, $229.6 million was available for share repurchases under the program.

During the year ended December 31, 2023, the Company repurchased 541,494 shares on the open market at an average price of $9.85 per share, for a total of $5.3 million, excluding brokerage commissions and accrued excise tax.

Additionally, in connection with secondary offerings of the Company’s common stock in March and May 2023, the Company repurchased 7,000,000 shares of its common stock sold in the offerings from the underwriters at a weighted average price of $10.48 per share concurrently with the closing of the offerings, for a total of $73.4 million, excluding accrued excise tax.

As of December 31, 2023, $234.6 million was available for additional share repurchases under the program.

During the year-ended December 31, 2022, the Company repurchased 1,970,763 shares on the open market at an average price of $9.82 per share, for a total of $19.4 million, excluding brokerage commissions.

Additionally, in connection with secondary offerings of the Company’s common stock in August and November 2022, the Company repurchased 14,500,000 shares of its common stock sold in the offerings from the underwriters at a weighted average price of $8.09 per share concurrently with the closing of the offerings, for a total of $117.3 million.

Additionally, in connection with secondary offerings of the Company’s common stock by an equity sponsor in March and May 2023, the Company repurchased 7,000,000 shares of its common stock in the offerings from underwriters at a weighted average price of $10.48 per share concurrently with the close of the offerings, for a total of $73.4 million, excluding accrued excise tax.

Basis of Presentation

1 unchanged sentence

We do not record sales by the Zeolyst Joint Venture as revenue and such sales are not consolidated within our results of operations.

However, net income and Adjusted EBITDA reflects our share of the earnings of the Zeolyst Joint Venture that have been recorded as equity in net income from affiliated companies in our consolidated statements of income and includes Zeolyst Joint Venture adjustments on a proportionate basis based on our 50% ownership interest.

However, net income and Adjusted EBITDA for the Company’s Advanced Materials & Catalysts segment reflects our 50% portion of the earnings from the Zeolyst Joint Venture that have been recorded as equity in net income in our consolidated statements of income and includes Zeolyst Joint Venture adjustments on a proportionate basis based on our 50% ownership interest.

Table of Con ten ts

Key Performance Indicators

2 unchanged sentences

Adjusted EBITDA and Adjusted Net Income are presented as key performance indicators as we believe these financial measures will enhance a prospective investor’s understanding of our results of operations and financial condition.

EBITDA consists of net income (loss) attributable t o continuing operations b efore interest, taxes, depreciation and amortization.

Adjusted EBITDA consists of EBITDA adjusted for (i) non-operating income or expense, (ii) the impact of certain non-cash, nonrecurring or other items included in net income (loss) and EBITDA that we do not consider indicative of our ongoing operating performance, and (iii) depreciation, amortization and interest of our 50% share of the Zeolyst Joint Venture.

Adjusted net income consists of net income (loss) adjusted for (i) non-operating income or expense and (ii) the impact of certain non-cash, nonrecurring or other items included in net income (loss) that we do not consider indicative of our ongoing operating performance.

EBITDA consists of net (loss) income attributable t o continuing operations b efore interest, taxes, depreciation and amortization.

Adjusted EBITDA consists of EBITDA adjusted for (i) non-operating income or expense, (ii) the impact of certain non-cash, nonrecurring or other items included in net (loss) income and EBITDA that we do not consider indicative of our ongoing operating performance, and (iii) depreciation, amortization and interest of our 50% share of the Zeolyst Joint Venture.

Adjusted Net Income consists of net (loss) income adjusted for (i) non-operating income or expense and (ii) the impact of certain non-cash, nonrecurring or other items included in net (loss) income that we do not consider indicative of our ongoing operating performance.

We believe that these non-GAAP financial measures provide investors with useful financial metrics to assess our operating performance from period-to-period by excluding certain items that we believe are not representative of our core business.

3 unchanged sentences

Our presentation of Adjusted EBITDA and Adjusted Net Income should not be construed as an inference that our future results will be unaffected by unusual or nonrecurring items.

Reconciliations of Adjusted EBITDA and adjusted net income to GAAP net income (loss) are included in the results of operations discussion that follows for each of the respective periods.

Reconciliations of Adjusted EBITDA and Adjusted Net Income to GAAP net (loss) income are included in the results of operations discussion that follows for each of the respective periods.

Key Factors and Trends Affecting Operating Results and Financial Condition

Overall, our Ecoservices and Advanced Materials & Catalysts segments continued to benefit from demand trends for our products and services in the industries we serve.

While sales of our virgin sulfuric acid into the production of nylon intermediates and sales of polyethylene catalysts weakened in the second half of 2023, demand across the balance of product categories, end-uses and customers throughout 2023 remained positive.

Contractual pass-through mechanisms and targeted price increases have served to mitigate the adverse impacts of inflationary pressures in 2023, including higher variable costs on our businesses and supply chain constraints, including limited availability and higher costs for energy, logistics, and other raw materials.

Overall, our Ecoservices and Advanced Materials & Catalysts segments continued to benefit from positive demand trends for our products and services in the majority of end uses we serve.

For Ecoservices, strong domestic and export demand for refined products continued to support high refinery utilization rates, while more stringent gasoline standards and growing demand for premium gasoline to power higher-compression and turbo-charged engines continued to drive demand for alkylate and for our regeneration services.

In addition, demand for virgin sulfuric acid across a wide range of industrial applications remained favorable.

For our Advanced Materials & Catalysts segment, global polyethylene demand remained positive, supporting our sales of polyethylene catalysts and catalysts supports.

Cost of Goods Sold

3 unchanged sentences

The primary raw materials for our Ecoservices segment include spent sulfuric acid, sulfur, acids, bases (including sodium hydroxide, or “caustic soda”) and certain metals.

Spent sulfuric acid for our Ecoservices segment is supplied by customers for a nominal charge as part of their contracts.

Spent sulfuric acid for our Ecoservices segment is supplied by customers as part of their contracts.

The primary raw materials used in the manufacture of products in our Advanced Materials & Catalysts segment include sodium silicate and cesium hydroxide.

During the second quarter of 2023, inflationary pressures began to ease, which reduced the cost of goods for sulfur, energy, logistics and other raw materials.

Most of our Ecoservices contracts feature take-or-pay volume protection and/or quarterly price adjustments for commodity inputs, labor, the Chemical Engineering Index (U.S.

chemical plant construction cost index) and natural gas.

Over 80% of our Ecoservices segment sales for the year ended December 31, 2023 were under contracts featuring quarterly price adjustments.

About 90% of our Ecoservices segment sales for the year ended December 31, 2024 were under contracts featuring quarterly price adjustments.

The price adjustments generally reflect actual costs for producing acid and tend to protect us from volatility in labor, fixed costs and raw material pricing.

The take-or-pay volume protection allows us to cover fixed costs through intermittent, temporary production issues at customer refineries.

Table of Con ten ts

While natural gas is not a direct feedstock for any product, natural gas powered machinery and equipment are used to heat raw materials and create the chemical reactions necessary to produce end-products.

We maintain multiple suppliers wherever possible and structure our customer contracts when possible to allow for the pass-through of raw material, labor and natural gas costs.

Joint Ventures

Joint Venture

We account for our investments in our equity joint ventures under the equity method.

3 unchanged sentences

Our regeneration services product group, which is a part of our Ecoservices segment, typically experiences seasonal fluctuations as a result of higher demand for gasoline products in the summer months and lower demand in the winter months.

These demand fluctuations results in higher sales and working capital requirements in the second and third quarters.

These demand fluctuations generally result in higher sales and working capital requirements in the second and third quarters.

Foreign Currency

As a global business, we are subject to the impact of gains and losses on currency translations, which occur when the financial stat ements of foreign operations are translated into U.S.

We operate in various geographies with approximately 6% of our sales for the years ended December 31, 2023 and 2022 in currencies other than the U.S.

We operate in various geographies with approximately 5% and 6% of our sales for the years ended December 31, 2024 and 2023, respectively are in currencies other than the U.S.

Because our consolidated financial results are reported in U.S.

5 unchanged sentences

The following is a summary of our financial performance for the year ended December 31, 2024 compared with the year ended December 31, 2023.

Sales decreased $129.1 million to $691.1 million.

The decrease in sales was primarily due to lower sales volume and the pass-through of lower sulfur costs, offset by higher average selling prices, after adjusting for impact of the pass-through of lower sulfur costs.

Gross profit decreased $26.8 million to $197.9 million.

The decrease in gross profit was primarily due to lower sales volume.

Sales increased $13.4 million to $704.5 million.

The increase in sales was primarily due to higher sales volume of regeneration services and virgin sulfuric acid, partially offset by lower average selling prices as a result of the pass-through of costs in Ecoservices.

Gross profit increased $3.6 million to $201.5 million.

The increase in gross profit was primarily due to higher sales volume and favorable variable costs, partially offset by lower average selling prices and unfavorable manufacturing costs.

Operating Income

Operating income decreased $7.7 million to $96.7 million.

The decrease in operating income was primarily due to the decrease in gross profit, offset by l ower selling, general and administrative expenses and other operating expenses .

Equity in Net Income from Affiliated Companies

Equity in net income of affiliated companies increased $2.9 million to $30.6 million.

The increase was primarily due to higher sales within the Zeolyst Joint Venture partially offset by the impact of unfavorable fixed cost absorption.

Operating income increased $1.3 million to $98.0 million.

The increase in operating income was primarily due to the increase in gross profit.

Equity in Net Income of Affiliated Companies

Equity in net income of affiliated companies decreased $15.5 million to $15.1 million.

The decrease was primarily due to lower earnings from the Zeolyst Joint Venture, driven by lower sales volume.

Table of Con ten ts

Impairment of Investment in Affiliated Companies

The following is our consolidated statement of income and a summary of financial results for the years ended December 31, 2024 and 2023.

December 31, Change

Years ended December 31, Change

2024 2023 $ %

9 unchanged sentences

Equity in net (income) from affiliated companies (15.1) (30.6) 15.5 (50.7) %

Impairment of investment in affiliated companies 65.0 — 65.0 NM

Interest expense, net 49.4 44.7 4.7 10.5 %

Other expense, net 0.6 0.2 0.4 200.0 %

Income from continuing operations before income taxes 82.0 94.7 (12.7) (13.4) %

Debt extinguishment costs 4.6 — 4.6 NM

Other (income) expense, net (0.8) 0.6 (1.4) (233.3) %

(Loss) income before income taxes (5.1) 82.0 (87.1) (106.2) %

Provision for income taxes 1.6 10.8 (9.2) (85.2) %

Effective tax rate (32.5) % 13.2 %

Net income from continuing operations 71.2 69.8 1.4 2.0 %

Net income from discontinued operations, net of tax — 3.9 (3.9) (100.0) %

Net income $ 71.2 $ 73.7 $ (2.5) (3.4) %

December 31, Change

Net (loss) income $ (6.7) $ 71.2 $ (77.9) (109.4) %

Years ended December 31, Change

2024 2023 $ %

4 unchanged sentences

Ecoservices :

Sales in Ecoservices for the year ended December 31, 2023 were $584.8 million, a decrease of $117.7 million, or 16.8%, compared with sales of $702.5 million for the year ended December 31, 2022.

The decrease in sales reflects lower sales volume of $52.1 million and the negative impact associated with the pass-through of lower sulfur costs of approximately $86 million, offset by higher average selling pricing of $20.4 million , after adjusting for the impact of the pass-through of lower sulfur costs.

Sales volume was lower primarily due to lower virgin sulfuric acid sales associated with the adverse impact of Winter Storm Elliott earlier in the year, extended maintenance turnaround activity at our facilities and lower end use demand of virgin sulfuric acid, primarily in the production of nylon intermediates.

Favorable pricing continued to benefit Ecoservices, driven by higher contractual and index pricing within regeneration services, as well as the pass-through of higher freight costs.

Sales in Ecoservices for the year ended December 31, 2024 were $598.3 million, an increase of $13.5 million, or 2.3%, compared with sales of $584.8 million for the year ended December 31, 2023.

The increase in sales reflects higher sales volume of $42.4 million, partially offset by lower average selling pricing of 28.9 million, inclusive of the negative impact associated with the pass-through of lower sulfur costs of approximately $7 million.

Sales volume increased driven by higher virgin sulfuric acid and regeneration services sales for the year ended December 31, 2024 as compared to the year ended December 31, 2023, which had the adverse impact of Winter Storm Elliott and extended maintenance turnaround activity at our facilities in 2023, as well as strong demand for regeneration services in the gulf coast in 2024.

Average selling prices were lower primarily due to the pass-through of lower costs, including sulfur, natural gas, freight and other variable costs, partially offset by favorable contract-pricing for regeneration services.

Table of Con ten ts

Advanced Materials & Catalysts :

Sales in Advanced Materials & Catalysts for the year ended December 31, 2023 were $106.3 million, a decrease of $11.4 million, or 9.7%, compared with sales of $117.7 million for the year ended December 31, 2022.

The decrease in sales was primarily due to lower sales volume of $24.2 million, partially offset by higher average selling prices of $12.4 million and the effects of foreign currency translation of $0.4 million.

The decrease in sales volume was primarily driven by lower end use demand for polyethylene catalysts and niche custom catalysts during the year ended December 31, 2023.

The higher average selling prices were primarily driven by implemented price increases.

Gross profit for the year ended December 31, 2023 was $197.9 million, a decrease of $26.8 million, or 11.9%, compared with $224.7 million for the year ended December 31, 2022.

The decrease in gross profit is primarily driven by lower sales volume of $30.1 million as well as unfavorable manufacturing costs of $29.5 million, partially offset by favorable average selling prices of $32.8 million, exclusive of the pass-through of sulfur costs.

Sales volume was lower primarily due to lower virgin sulfuric acid sales and lower polyethylene catalysts sales.

The unfavorable manufacturing costs was primarily driven by costs related to the extended maintenance turnaround activity, planned turnaround activity, and higher unplanned repair and maintenance costs.

Sales in Advanced Materials & Catalysts for the year ended December 31, 2024 were $106.2 million, a decrease of $0.1 million, compared with sales of $106.3 million for the year ended December 31, 2023.

The change in sales was primarily due to lower sales volume and mix of $0.4 million, partially offset by higher average selling prices of $0.3 million.

The change in volume reflects higher sales for finished polyethylene catalysts and niche custom catalysts, offset by lower sales of polyethylene catalyst supports during the year ended December 31, 2024.

Gross profit for the year ended December 31, 2024 was $201.5 million, an increase of $3.6 million, or 1.8%, compared with $197.9 million for the year ended December 31, 2023.

The increase in gross profit is primarily driven by higher sales volume and mix of $22.8 million, unfavorable manufacturing costs of $2.4 million and lower average selling prices of $21.6 million, exclusive of the pass-through of sulfur costs.

The increase in sales volume was primarily related to higher demand for regeneration services and virgin sulfuric acid.

Higher manufacturing costs was primarily driven by general inflation, higher planned maintenance costs and costs associated with our manufacturing plant reliability improvement program in Ecoservices.

Average selling prices were lower primarily due to the pass-through of lower costs, including sulfur, natural gas, freight and other variable costs.

Selling, General and Administrative Expenses

Selling, general and administrative expenses for the year ended December 31, 2023 were $79.2 million, a decrease of $6.1 million compared with $85.3 million for the year ended December 31, 2022.

The decrease in selling, general and administrative expenses was mainly due to a decrease in compensation related costs of $6.3 million and a decrease in stock-based compensation expense of $4.6 million driven by fewer overall awards granted and outstanding for the year ended December 31, 2023.

This was partly offset by an increase in professional fees of $3.4 million primarily related to consulting and recruiting charges.

Selling, general and administrative expenses for the year ended December 31, 2024 were $83.9 million, an increase of $4.7 million compared with $79.2 million for the year ended December 31, 2023.

The increase in selling, general and administrative expenses was primarily due to an increase in other compensation-related expenses of $12.4 million, partially offset by decreases in stock compensation of $2.0 million, professional fees of $2.1 million and other expenses of $3.8 million.

Other Operating Expense, Net

Other operating expense, net for the year ended December 31, 2023 was $22.0 million, a decrease of $13.0 million, or 37.1%, compared with $35.0 million for the year ended December 31, 2022.

The decrease in other operating expense, net was mainly driven by severance charges incurred in the prior period from contracts associated with fo rmer executives and residual costs from the sale of the Performance Chemicals business and other transactions costs for the year ended December 31, 2022 .

Equity in Net Income from Affiliated Companies

Equity in net income from affiliated companies for the year ended December 31, 2023 was $30.6 million, an increase of $2.9 million or 10.5%, compared with $27.7 million for the year ended December 31, 2022.

The increase was primarily due to higher sales for hydrocracking, sustainable fuels and emission control catalysts within the Zeolyst Joint Venture partially offset by the impact of unfavorable fixed cost absorption during the year ended December 31, 2023 as compared to the year ended December 31, 2022.

Other operating expense, net for the year ended December 31, 2024 was $19.6 million, a decrease of $2.4 million compared with $22.0 million for the year ended December 31, 2023.

The decrease in other operating expense, net was mainly driven by smaller losses on asset disposals during the year ended December 31, 2024 and residual costs from the sale of the Performance Chemicals business and other transactions costs that occurred during the year ended December 31, 2023 .

The Company recorded an impairment on an intangible asset of $3.9 million during the year ended December 31, 2024.

Equity in Net Income of Affiliated Companies

Equity in net income of affiliated companies for the year ended December 31, 2024 was $15.1 million, a decrease of $15.5 million as compared with $30.6 million for the year ended December 31, 2023.

The decrease was primarily due to lower sales for hydrocracking and emission control catalysts and lower sales of catalysts used in the production of sustainable fuels within the Zeolyst Joint Venture during the year ended December 31, 2024 as compared to the year ended December 31, 2023.

Impairment of Investment in Affiliated Companies

During the year ended December 31, 2024 , we recognized an impairment charge of $65 million on our investment in the Zeolyst Joint Venture to reduce the carrying value of our investment to its estimated fair value, which declined primarily due to the demand outlook for catalyst materials used in emission control applications and the production of sustainable fuels.

In May 2016, as a result of a business combination, the investment in the Zeolyst Joint Venture was increased through purchase accounting fair value adjustments.

This impairment was a partial reduction to the goodwill and trade name components of the purchase accounting fair value adjustments recorded as a result of the 2016 business combination.

Interest Expense, Net

Interest expense, net for the year ended December 31, 2024 was $49.4 million, an increase of $4.7 million, as compared with $44.7 million for the year ended December 31, 2023.

The increase in interest expense was due to year over year increase in variable rates, which was partially offset by lower outstanding debt for the year ended December 31, 2023 , as compared to the year ended December 31, 2022.

This was offset by the benefits associated with our interest rate caps, which included an adjustment related to prior year interest rate amortization.

Other Expense, Net

Other expense, net was $0.6 million for the year ended December 31, 2023, an increase of $0.4 million, compared with $0.2 million for the year ended December 31, 2022.

The change primarily related to a $1.6 million change in net gains in foreign currency translation in the current year and a change of $1.1 million in pension plan costs.

The increase in interest expense, net was primarily due to year over year increase in variable rates and the decrease in the benefits associated with our interest rate caps, partially offset by lower outstanding debt for the year ended December 31, 2024 , as compared to the year ended December 31, 2023 and the reductions in our spread associated with the June 2024 refinancing.

Table of Con ten ts

Debt Extinguishment Costs

Debt extinguishment costs for the year ended December 31, 2024 were $4.6 million .

On June 12, 2024, the Company amended its existing senior secured term loan facility to reduce the applicable interest rates and extend the maturity of the facility to June 2031.

The Company evaluated the terms of the amendment in accordance with ASC 470-50 Debt - Modification and Extinguishment and determined that the amendment was primarily a modification of debt.

As a result, we recorded $4.5 million of third-party financing fees as debt extinguishment costs in the consolidated statements of income during the year ended December 31, 2024 .

In addition, previously unamortized deferred financing costs and original issue discount of $0.1 million associated with the existing senior secured term loan facility were written off as debt extinguishment costs for the year ended December 31, 2024 .

In January 2025, the Company re-priced the 2024 Term Loan Facility to reduce the applicable interest rate.

The terms of the facility were substantially consistent following the re-pricing, except that borrowings under the facility will bear interest at a rate equal to term SOFR plus 2.00% per annum.

Other (Income) Expense, Net

Other (income) expense, net for the year ended December 31, 2024 was income of $0.8 million, a change of $1.4 million, compared with expense of $0.6 million for the year ended December 31, 2023.

The change primarily related to the sale of environmental credits during the year ended December 31, 2024.

Provision for Income Taxes

2 unchanged sentences

The difference between the U.S.

federal statutory income tax rate and our effective income tax rate for the year ended December 31, 2023 was mainly due to the impact of a valuation allowance release connected to our state investment tax credit carryovers, foreign tax credit benefit, the Section 162(m) deduction limitation for “covered” employees with compensation in excess of $1 million, along with the tax deductibility of stock compensation.

federal statutory income tax rate and our effective income tax rate for the year ended December 31, 2024 was mainly due to the impact of the tax deductibility of the impairment of investment in affiliated companies, the statute of limitations expiration related to prior year uncertain tax positions, foreign tax credit benefit and research and development tax credit benefit.

The difference between the U.S.

federal statutory income tax rate and our effective income tax rate for the year ended December 31, 2022 was mainly due the impact of the Section 162(m) deduction limitation for “covered” employees with compensation in excess of $1 million, along with the tax deductibility of stock compensation.

For the foregoing reasons, net income was $71.2 million for the year ended December 31, 2023 as compared to $73.7 million for the year ended December 31, 2022.

federal statutory income tax rate and our effective income tax rate for the year ended December 31, 2023 was mainly due the impact of a valuation allowance release connected to our state investment tax credit carryovers, foreign tax credit benefit, the Section 162(m) deduction limitation for “covered” employees with compensation in excess of $1 million, along with the tax deductibility of stock compensation.

Net Loss (Income)

For the foregoing reasons, net loss was $6.7 million for the year ended December 31, 2024 as compared to net income of $71.2 million for the year ended December 31, 2023.

Adjusted EBITDA

Summarized EBITDA and Adjusted EBITDA information is shown below in the following table:

December 31, Change

Years ended December 31, Change

2024 2023 $ %

10 unchanged sentences

Adjusted EBITDA may not be comparable with EBITDA or Adjusted EBITDA as defined by other companies.

Table of Con ten ts

(2) The Adjusted EBITDA from the Zeolyst Joint Venture included in the Advanced Materials & Catalysts segment was $32.2 million for the year ended December 31, 2024, which includes $15.1 million of equity in net income, excluding $3.8 million of amortization of investment in affiliate step-up plus $13.3 million of joint venture depreciation, amortization and interest.

1 unchanged sentence

Ecoservices :

Adjusted EBITDA for the year ended December 31, 2023 was $200.0 million, a decrease of $27.8 million, or 12.2%, compared to $227.8 million for the year ended December 31, 2022.

The decrease in Ecoservices’ Adjusted EBITDA was the result of lower sales volumes for virgin sulfuric acid, as well as higher unplanned repair and maintenance costs associated with production downtime at several of our manufacturing sites and the associated impact from Winter Storm Elliott, partially offset by higher average selling prices, excluding the pass-through of lower sulfur costs .

Favorable pricing continued to benefit Ecoservices driven by higher contractual pricing and index pricing within regeneration services as well as the pass through of higher freight costs.

The Winter Storm Elliott and unplanned production downtime drove both lower sales of virgin sulfuric acid as well as higher maintenance costs during the year.

In addition, the lower volume was driven by a decrease in demand for virgin sulfuric acid used in the production of nylon intermediates.

Adjusted EBITDA for the year ended December 31, 2024 was $200.3 million, an increase of $0.3 million, or 0.2%, compared to $200.0 million for the year ended December 31, 2023.

The change in Adjusted EBITDA was a result of higher sales volumes and favorable contract pricing, largely offset by higher transportation costs and planned maintenance costs inclusive of turnarounds, as well as unfavorable net pricing, reflecting the timing and contractual pass-through of certain costs, including energy and other indexed costs.

Advanced Materials & Catalysts:

Adjusted EBITDA for the year ended December 31, 2023 was $81.9 million, an increase of $3.9 million, or 5.0%, compared with $78.0 million for the year ended December 31, 2022.

Adjusted EBITDA increased due higher average selling prices from implemented price increases, partially offset by lower volume from decreased demand for polyethylene catalysts and the timing of niche custom catalyst sales.

In addition, within the Zeolyst Joint Venture, strong pricing and higher sales of hydrocracking catalyst, emission control catalyst and catalyst used in the production of sustainable fuels was offset by higher manufacturing costs and the year-over-year impact of prior year unfavorable fixed cost absorption.

A reconciliation of net income attributable to Ecovyst Inc.

to Adjusted EBITDA is as follows:

Adjusted EBITDA for the year ended December 31, 2024 was $64.7 million, a decrease of $17.2 million, or 21.0%, compared with $81.9 million for the year ended December 31, 2023.

Adjusted EBITDA decreased primarily due to lower sales volume within the Zeolyst Joint Venture.

A reconciliation of net (loss) income to Adjusted EBITDA is as follows:

Years ended December 31,

(in millions)

Reconciliation of net income to Adjusted EBITDA

Net income from continuing operations $ 71.2 $ 69.8

Reconciliation of net (loss) income to Adjusted EBITDA

Net (loss) income $ (6.7) $ 71.2

Provision for income taxes 1.6 10.8

4 unchanged sentences

Amortization of investment in affiliate step-up (b)

Net loss on asset disposals (c)

Foreign currency exchange (gain) loss (d)

LIFO expense (benefit) (e)

Transaction and other related costs (f)

Impairment of investment in affiliated companies (c)

Intangible asset impairment charge 3.9 —

Debt extinguishment costs 4.6 —

Net loss on asset disposals (d)

Foreign currency exchange gain (e)

LIFO (benefit) expense (f)

Transaction and other related costs (g)

Equity-based compensation 14.0 16.0

Restructuring, integration and business optimization expenses (g)

Restructuring, integration and business optimization expenses (h)

Adjusted EBITDA $ 238.2 $ 259.9

Table of Con ten ts

(a) We use Adjusted EBITDA as a performance measure to evaluate our financial results.

Because our Advanced Materials & Catalysts segment includes our 50% interest in the Zeolyst Joint Venture, we include an adjustment for our 50% proportionate share of depreciation, amortization and interest expense of the Zeolyst Joint Venture.

Because our Advanced Materials & Catalysts segment reflects our 50% portion of the earnings from the Zeolyst Joint Venture, we include an adjustment for our 50% proportionate share of depreciation, amortization and interest expense of the Zeolyst Joint Venture.

(b) Represents the amortization of the fair value adjustments associated with the equity affiliate investment in the Zeolyst Joint Venture as a result of the combination of the businesses of PQ Holdings Inc.

2 unchanged sentences

Amortization is primarily related to the fair value adjustments associated with intangible assets, including customer relationships and technical know-how.

(c) When asset disposals occur, we remove the impact of net gain/loss of the disposed asset because such impact primarily reflects the non-cash write-off of long-lived assets no longer in use.

(d) Reflects the exclusion of the foreign currency transaction gains and losses in the statements of income related to the non-permanent intercompany debt denominated in local currency translated to U.S.

(e) Represents non-cash adjustments to the Company’s LIFO reserves for certain inventories in the U.S.

that are valued using the LIFO method, effectively reflecting the results as if these inventories were valued using the FIFO

method, which we believe provides a means of comparison to other companies that may not use the same basis of accounting for inventories.

(f) Relates to certain transaction costs, including debt financing, due diligence and other costs related to transactions that are completed, pending or abandoned, that we believe are not representative of our ongoing business operations.

(g) Includes the impact of restructuring, integration and business optimization expenses, which are incremental costs that are not representative of our ongoing business operations.

(h) Other consists of adjustments for items that are not core to our ongoing business operations.

During the year ended December 31, 2024, we recognized an impairment charge on our investment in the Zeolyst Joint Venture to reduce the carrying value of our investment to its estimated fair value.

This impairment was an adjustment to the goodwill component of the purchase accounting fair value adjustments recorded as a result of the combination of the businesses of PQ Holdings Inc.

and Eco Services Operations LLC in May 2016.

(d) When asset disposals occur, we remove the impact of net gain/loss of the disposed asset because such impact primarily reflects the non-cash write-off of long-lived assets no longer in use.

(e) Reflects the exclusion of the foreign currency transaction gains and losses in the statements of income related to the remeasurement effects of monetary assets and liabilities, including non-permanent intercompany debt, denominated in foreign currency.

(f) Represents non-cash adjustments to the Company’s LIFO reserves for certain inventories in the U.S.

that are valued using the LIFO method, effectively reflecting the results as if these inventories were valued using the FIFO method, which we believe provides a means of comparison to other companies that may not use the same basis of accounting for inventories.

(g) Relates to certain transaction costs, including debt financing, due diligence and other costs related to transactions that are completed, pending or abandoned, that we believe are not representative of our ongoing business operations.

(h) Includes the impact of restructuring, integration and business optimization expenses, which are incremental costs that are not representative of our ongoing business operations.

(i) Other consists of adjustments for items that are not core to our ongoing business operations.

These adjustments include environmental remediation and other legal costs, expenses for capital and franchise taxes, and defined benefit pension and postretirement plan (benefits) costs, for which our obligations are under plans that are frozen.

1 unchanged sentence

Included in this line-item are rounding discrepancies that may arise from rounding from dollars (in thousands) to dollars (in millions).

Table of Con ten ts

Adjusted Net Income

3 unchanged sentences

(in millions)

Reconciliation of net income to Adjusted Net Income (1)(2)

Net income from continuing operations $ 82.0 $ 10.8 $ 71.2 $ 94.7 $ 24.9 $ 69.8

Reconciliation of net (loss) income to Adjusted Net Income (1)(2)

Net (loss) income $ (5.1) $ 1.6 $ (6.7) $ 82.0 $ 10.8 $ 71.2

Amortization of investment in affiliate step-up (b)

3.8 1.0 2.8 6.4 1.6 4.8

Net loss on asset disposals (c)

Impairment of investment in affiliated companies (c)

65.0 0.5 64.5 — — —

Foreign currency exchange (gain) loss (d)

Intangible asset impairment charge 3.9 1.0 2.9 — — —

Debt extinguishment costs 4.6 1.2 3.4 — — —

Net loss on asset disposals (d)

2.4 0.6 1.8 4.1 1.0 3.1

LIFO expense (benefit) (e)

Foreign currency exchange gain (e)

(0.2) (0.1) (0.1) (1.3) (0.3) (1.0)

Transaction and other related costs (f)

LIFO (benefit) expense (f)

(2.2) (0.6) (1.6) 3.5 0.9 2.6

Transaction and other related costs (g)

0.4 0.1 0.3 3.0 0.8 2.2

Equity-based compensation 14.0 3.0 11.0 16.0 1.5 14.5

Restructuring, integration and business optimization expenses (g)

Restructuring, integration and business optimization expenses (h)

1.0 0.3 0.7 2.7 0.7 2.0

(1.5) (0.5) (1.0) 0.8 0.2 0.6

Adjusted Net Income, including Impact valuation allowance release 117.2 17.2 100.0 144.4 31.2 113.2

Adjusted Net Income, including impact of valuation allowance release and changes in uncertain tax positions release 86.1 8.1 78.0 117.2 17.2 100.0

Impact of valuation allowance release (3)

— — — — 10.2 (10.2)

Changes in uncertain tax positions release (4)

— 9.4 (9.4) — — —

Adjusted Net Income $ 86.1 $ 17.5 $ 68.6 $ 117.2 $ 27.4 $ 89.8

(1) We define adjusted net inco me as net income attributable to Ecovyst Inc.

adjusted for non-operating income or expense and the impact of certain non-cash or other items that are included in net income that we do not consider indicative of our ongoing operating performance.

Adjusted net income is presented as a key performance indicator as we believe it will enhance a prospective investor’s understanding of our results of operations and financial

Adjusted net income may not be comparable with net income or adjusted net income as defined by other companies.

(1) We define Adjusted Net Inco me as net (loss) income adjusted for non-operating income or expense and the impact of certain non-cash or other items that are included in net (loss) income that we do not consider indicative of our ongoing operating performance.

Adjusted Net Income is presented as a key performance indicator as we believe it will enhance a prospective investor’s understanding of our results of operations and financial condition.

Adjusted Net Income may not be comparable with net (loss) income or Adjusted Net Income as defined by other companies.

(2) Ref er to the Adjusted EBITDA notes above for more information with respect to each adjustment.

1 unchanged sentence

Item is not expected to be recurring.

The adjustments to net income attributable to Ecovyst Inc.

are shown net of each applicable statutory tax rates of 25.4% and 23.9% for the year ended December 31, 2023 and 2022, respectively, except for equity-based compensation.

(4) Represents the tax impact of previously net unrecognized tax benefits, excluding interest and penalties, primarily due to the expiration of statutes of limitations.

The adjustments to net income are shown net of applicable tax rates of 25.3% and 25.4% for the years ended December 31, 2024 and 2023, respectively, except for equity-based compensation and the impairment of investment in affiliated companies.

The tax effect on equity-based compensation is derived by removing the tax effect of any equity-based compensation expense disallowed as a result of its inclusion within IRC Sec.

162(m), and adding the tax effect of equity-based stock compensation shortfall recorded as a discrete item.

162(m) and adding the tax effect of equity-based compensation shortfall recorded as a discrete item.

The tax effect on the impairment of investment in affiliated companies is derived by removing the tax impact of the non-deductible component specific to goodwill.

Table of Con ten ts

Results of Operations

5 unchanged sentences

Our primary liquidity requirements include funding working capital requirements (primarily inventory and accounts receivable, net of accounts payable and other accrued liabilities), debt service requirements and capital expenditures.

Our capital expenditures include both maintenance of business, which include spending on maintenance and HSE initiatives as well as growth, which includes spending to drive organic sales growth and cost savings initiatives.

We believe that our existing cash, cash equivalents and cash flows from operations, combined with availability under our ABL Facility, will be sufficient to meet our presently anticipated future cash needs for at least the next twelve months.

Our capital expenditures include both maintenance of business, which include spending on maintenance and health, safety and environmental initiatives as well as growth, which includes spending to drive organic sales growth and cost savings initiatives.

We believe that our existing cash and cash equivalents and cash flows from operations, combined with availability under our ABL Facility, will be sufficient to meet our presently anticipated future cash needs for at least the next twelve months.

We may also pursue strategic acquisition or divestiture opportunities, which may impact our future cash requirements.

1 unchanged sentence

As of December 31, 2024, we had cash and cash equivalents of $146.0 million and availability of $75.2 million under our ABL Facility, after giving effect to $3.3 million of outstanding letters of credit, for a total available liquidity of $221.2 million.

As of December 31, 2023, we did not have any revolving credit facility borrowings and were in compliance with all covenants under our debt agreements.

We did not have any revolving credit facility borrowings as of December 31, 2024.

As of December 31, 2024, we were in compliance with all covenants under our debt agreements.

Our ABL Facility has one financial covenant with two ratios to maintain.

7 unchanged sentences

Each limits the ability of the Company and its restricted subsidiaries to incur certain indebtedness or liens, merge, consolidate or liquidate, dispose of certain property, make investments or declare or pay dividends, make optional payments, modify certain debt instruments, enter into certain transactions with affiliates, enter into certain sales and leasebacks and certain other non-financial restrictive covenants.

The ABL Facility also contains one financial covenant which applies when minimum availability under the ABL Facility exceeds a certain threshold.

During such time, the Company is required to maintain a fixed-charge coverage ratio of at least 1.0 to 1.0.

The Company was in compliance with all debt covenants under the 2021 Term Loan Facility and the ABL Facility as of December 31, 2023 and 2022, respectively.

The Company was compliant with all debt covenants under the 2024 Term Loan Facility and the ABL Facility as of December 31, 2024 and 2023, respectively.

Included in our cash and cash equivalents balance as of December 31, 2024 was $9.6 million of cash and cash equivalents in foreign jurisdictions.

2 unchanged sentences

Repatriation of foreign cash is generally not subject to U.S.

federal income taxes at the time of cash

distribution.

federal income taxes at the time of cash distribution.

However, foreign earnings may still be taxed for state income tax purposes, as well as subject to certain foreign withholding tax obligations, when cash amounts are distributed back to the U.S.

6 unchanged sentences

The principal balance due in the next twelve months is $8.7 million.

Table of Con ten ts

Interest payments due within the next twelve months are $50.1 million using the interest rate effective as of December 31, 2024 on our variable interest credit facilities.

12 unchanged sentences

Operating lease payments due within the next twelve months is $11.0 million.

As of December 31, 2023, our total finance lease liabilities was $0.1 million as of December 31, 2023, with $0.1 million of principal and interest payments made during the year.

Finance lease payments due withing the next twelve months is $0.1 million.

As of December 31, 2023, our total finance obligation was $7.9 million as of December 31, 2023, with $3.1 million of principal and interest payments made during the year.

Finance obligation due withing the next twelve months is $3.2 million.

As of December 31, 2024, our total finance lease liabilities was $0.02 million and due within in the next twelve months.

Principal and interest payments made during the year was $0.1 million.

As of December 31, 2024, our total finance obligation was $4.9 million, with $3.1 million of principal and interest payments made during the year.

Finance obligation due within the next twelve months is $3.1 million.

Years ended December 31,

2024 2023 2022

6 unchanged sentences

Discontinued Operations

Net cash provided by (used in)

Net cash provided by

Operating activities — — 6.3

Investing activities — — (40.0)

Financing activities — — (1.1)

Effect of exchange rate changes on cash and cash equivalents (0.9) (1.3) (5.5)

2 unchanged sentences

Cash and cash equivalents at end of period $ 146.0 $ 88.4 $ 111.0

2023 2022 2021

(in millions)

Continuing Operations

Net income $ 71.2 $ 69.8 $ 1.8

Non-cash and non-working capital related activities (1)

86.6 114.3 156.6

Changes in working capital (20.8) (2.2) (18.1)

Other operating activities 0.6 (1.5) (3.0)

Net cash provided by operating activities, continuing operations $ 137.6 $ 180.4 $ 137.3

(1) Includes depreciation, amortization, amortization of deferred financing costs and original issue discount, debt extinguishment costs, foreign currency exchange (gain) loss, pension and postretirement healthcare (benefit) expense, deferred income tax provision (benefit), net (gain) loss on asset disposals, stock compensation expense, equity in net income and dividends received from affiliated companies.

2023 2022 2021

(in millions)

Continuing Operations

Working capital changes that provided (used) cash:

Receivables $ (6.1) $ 5.4 $ (33.5)

Inventories (1.4) 9.9 0.6

Prepaids and other current assets (1.1) — (7.8)

Accounts payable 2.4 (10.1) 10.0

Accrued liabilities (14.6) (7.4) 12.6

$ (20.8) $ (2.2) $ (18.1)

2023 2022 2021

(in millions)

Continuing Operations

Purchases of property, plant and equipment $ (65.3) $ (58.9) $ (60.0)

Proceeds from business divestitures, net of cash — — 978.4

Payments for business divestiture, net of cash — (3.7) —

Business combinations, net of cash acquired — (0.5) (42.6)

Other, net — 0.1 (0.1)

Net cash (used in) provided by investing activities, continuing operations $ (65.3) $ (63.0) $ 875.7

2023 2022 2021

(in millions)

Continuing Operations

Cash repayments on debt obligations $ (9.0) $ (9.0) $ (542.9)

Dividends paid to stockholders — — (435.6)

Repurchases of common shares (78.7) (136.7) —

Tax withholdings on equity award vesting (3.4) (0.3) —

Repayment of financing obligation (2.8) (2.7) —

Other financing activities 0.4 0.6 15.4

Net cash used in financing activities, continuing operations $ (93.5) $ (148.1) $ (963.1)

The following discussions related to our cash flows are presented on a continuing operations basis, which excludes the cash flows from our former Performance Chemicals and Performance Materials businesses, which are accounted for as discontinued operations.

Table of Con ten ts

The following discussions related to our cash flows are presented on a continuing operations basis, which excludes the cash flows from our former Performance Chemicals business, which was accounted for as discontinued operations.

Year Ended December 31, 2024 compared to the Year Ended December 31, 2023

Net cash provided by operating activities was $149.9 million for the year ended December 31, 2024, compared with $137.6 million provided for the year ended December 31, 2023.

Cash generated by operating activities, other than changes in working capital was lower by $24.1 million during the year ended December 31, 2023, as compared to the prior year was primarily driven by lower earnings, lower dividends from affiliates, higher cash taxes and cash interest, and unfavorable change in working capital .

The decrease in cash from working capital during the year ended December 31, 2023 of $18.6 million was unfavorable compared to the year ended December 31, 2022 primarily due to unfavorable changes in receivables, inventories, prepaids and other current assets and accrued liabilities, which were offset by favorable change in accounts payable.

The unfavorable change in receivables was driven by the timing of sales orders and collections.

The unfavorable change in inventory was primarily due to the timing of sales orders and inventory build.

The unfavorable change in prepaid and other current assets primarily relates to the timing of interest receivable and non-trade receivables from related parties.

The unfavorable change in accrued liabilities primarily relates to changes in payments for other compensation-related liabilities in the current period.

The favorable change in accounts payable is due to the timing of vendor payments.

Cash generated by operating activities, other than changes in working capital was higher by $12.3 million during the year ended December 31, 2024, as compared to the prior year which was primarily driven by higher dividends received from affiliates, offset by lower earnings, higher cash taxes and cash interest paid .

The decrease in cash from working capital during the year ended December 31, 2024 of $0.1 million was unfavorable compared to the year ended December 31, 2023 primarily due to unfavorable changes in inventories and accrued liabilities, which were partially offset by favorable changes in receivables, prepaids and other current assets.

The unfavorable change in inventories was primarily due to the timing of sales orders and inventory build.

The unfavorable change in accrued liabilities primarily relates to timing of payments for variable employee compensation liabilities.

The favorable change in receivables was driven by the timing of collection of sales.

The favorable change in prepaids and other current assets primarily relates to the timing of interest and other receivables.

Net cash used in investing activities was $73.5 million for the year ended December 31, 2024, compared to net cash used of $65.3 million during the year ended December 31, 2023.

Cash used in investing activities consisted of $69.0 million and $65.3 million to fund capital expenditures during the years ended December 31, 2024 and 2023, respectively.

During the year ended December 31, 2022, we made an additional payment of $3.7 million related to our divestiture of our Performance Chemicals business representing the final adjustments to the sale price.

The Company paid $4.5 million to complete a minority equity investment in Pajarito Powder LLC during the year ended December 31, 2024 .

Net cash used in financing activities was $17.9 million for the year ended December 31, 2024, compared with $93.5 million used during the year ended December 31, 2023.

Net cash used in financing activities was driven by fewer repurchases of common stock of $58.0 million in December 31, 2023 compared to December 31, 2022.

Net cash used in financing activities was driven by the lower repurchases of the Company’s common stock of $73.7 million during the year ended December 31, 2024 compared to December 31, 2023.

Year Ended December 31, 2023 compared to the Year Ended December 31, 2022

1 unchanged sentence

(in millions)

Senior Secured Term Loan Facility due June 2028 $ 877.5 $ 886.5

2024 Term Loan Facility $ 870.8 $ 877.5

ABL Facility — —

8 unchanged sentences

Our total available liquidity as of December 31, 2024 was $221.2 million, which represents our cash on hand of $146.0 million plus our excess availability under our ABL of $75.2 million, after giving effect to $3.3 million of outstanding letters of credit and no revolving credit facility borrowings.

We may seek, subject to market conditions and other factors, opportunities to repurchase, refinance or otherwise reprice our debt.

Table of Con ten ts

may seek, subject to market conditions and other factors, opportunities to repurchase, refinance or otherwise reprice our debt.

2024 Term Loan Facility

On June 9, 2021, we entered into an agreement for a senior secured term loan facility (the “2021 Term Loan Facility”) in an aggregate principal amount of $900.0 million, with an original issue discount of 0.25% and interest at a floating rate of LIBOR (with a 0.50% minimum LIBOR floor) plus 2.75% per annum (or, depending on the Borrower’s first lien net leverage ratio, 2.50%), with a maturity date of June 9, 2028.

The 2021 Term Loan Facility required scheduled quarterly amortization payments, each equal to 0.25% of the original principal amount of the loans under the 2021 Term Loan Facility.

The proceeds from the 2021 Term Loan Facility were used to repay the senior secured term loan facility we entered into an agreement in 2020 in full and partially repay the senior secured term loan facility we entered into an agreement in 2018.

On February 9, 2023, we amended the 2021 Term Loan Facility to replace LIBOR with a Secured Overnight Financing Rate (“SOFR”) as the benchmark interest rate.

Following this amendment, the 2021 Term Loan Facility bears interest at an adjusted SOFR rate (with a 0.50% minimum floor) plus 2.75% per annum (or, depending on the first lien net leverage ratio, 2.50%).

On June 12, 2024, we amended the 2021 Term Loan Facility, to among other things, (a) reduce the interest rate applicable to all outstanding SOFR term loans to term SOFR plus 2.25% per annum from a maximum of adjusted term SOFR plus 2.75% per annum, (b) reduce the interest rate applicable to all outstanding base rate term loans to the alternate base rate plus 1.25% per annum from a maximum of the alternate base rate plus 1.75% per annum and (c) extend the maturity date of all outstanding term loans to June 12, 2031 (the amended term loans, the “2024 Term Loan Facility”).

As a result of the amendment, there is no longer a credit spread adjustment of 10 basis points.

On January 30, 2025, the Company amended the 2024 Term Loan Facility to, among other things, (a) reduce the interest rate applicable to all outstanding SOFR term loans to term SOFR plus 2.00% per annum from a maximum of term SOFR plus 2.25% per annum and (b) reduce the interest rate applicable to all outstanding base rate term loans to the alternate base rate plus 1.00% per annum from a maximum of the alternate base rate plus 1.25% per annum.

On May 4, 2016, we entered a $200.0 million senior secured ABL facility, which provided for $200.0 million in revolving credit commitments.

3 unchanged sentences

In addition, there was an annual commitment fee equal to 0.375%, with a step-down to 0.25% based on average usage of the revolving credit borrowings available.

Following the amendment, the borrowings under the amended ABL Facility bore interest at a rate equal to the LIBOR rate or the base rate plus a margin of between 1.25% to 1.75% or 0.25% to 0.75%, respectively.

Following the amendment, the borrowings under the amended ABL Facility bear interest at a rate equal to the LIBOR rate or the base rate plus a margin of between 1.25% to 1.75% or 0.25% to 0.75%, respectively.

On June 9, 2021, we amended the ABL Facility a third time to decrease the aggregate amount of revolving loan commitments available to $100.0 million, consisting of $90.0 million in U.S.

commitments and $10.0 million in European commitments and extended the maturity date to August 2, 2026.

On February 17, 2023, we amended the ABL Facility to replace LIBOR with a secured overnight financing rate (“SOFR”) as the benchmark interest rate with respect to U.S.

On February 17, 2023, we amended the ABL Facility to replace LIBOR with SOFR as the benchmark interest rate with respect to U.S.

dollar-denominated borrowings.

6 unchanged sentences

We were in compliance with all debt covenants as of December 31, 2024 and 2023, respectively.

2021 Term Loan Facility

The 2021 Term Loan Facility requires scheduled quarterly amortization payments, each equal to 0.25% of the original principal amount of the loans under the 2021 Term Loan Facility.

The proceeds from the 2021 Term Loan Facility were used to repay the 2020 Term Loan Facility in full and partially repay the 2018 Term Loan Facility.

On February 9, 2023, we amended the 2021 Term Loan Facility to replace LIBOR with SOFR as the benchmark interest rate.

Table of Con ten ts

Capital Expenditures

2 unchanged sentences

These capital expenditures represent our “book” capital expenditures for which the Company has recorded, but not necessarily paid for the capital expenditures.

Years ended December 31,

2024 2023 2022

4 unchanged sentences

Capital expenditures remained at a level sufficient for required maintenance and certain expansion growth initiatives during these periods.

Maintenance capital expenditures were higher in the year ended December 31, 2023 as compared to December 31, 2022 due to extended turnaround activities and additional expenditures incurred related to Winter Storm Elliott impacting our manufacturing facilities earlier in the year.

Growth capital expenditures are slightly lower in the year ended December 31, 2023 as compared to December 31, 2022 due to the completion of several expansion projects in 2022.

Maintenance capital expenditures were slightly lower in the year ended December 31, 2024 as compared to December 31, 2023 due to extended turnaround activities and additional expenditures incurred related to Winter Storm Elliott impacting our manufacturing facilities in 2023.

Growth capital expenditures were higher in the year ended December 31, 2024 as compared to December 31, 2023 primarily due to the planned expansion of the Kansas City Advanced Silicas catalyst coating facility.

Pension Funding

We paid an immaterial amount in cash contributions into our defined benefit pension plans and other postretirement plans in December 31, 2023, 2022, and 2021.

We paid $1.6 million in contributions into our defined benefit pension plans and other postretirement plans in December 31, 2024 and immaterial amounts in December 31, 2023 and 2022.

The net periodic pension and postretirement expense (benefit) was $(0.2) million, $0.1 million, and $(1.0) million for those same periods, respectively.

17 unchanged sentences

We identify a contract when an agreement with a customer creates legally enforceable rights and obligations, which occurs when a contract has been approved by both parties, the parties are committed to perform their respective obligations, each party’s rights and payment terms are clearly identified, commercial substance exists and it is probable that we will collect the consideration to which we are entitled.

Table of Con ten ts

Evidence of a contract with a customer may take the form of a master service agreement (“MSA”), a MSA in combination with an underlying purchase order, a combination of a pricing quote with an underlying purchase order or an individual purchase order received from a customer.

8 unchanged sentences

Certain of our contracts include multiple performance obligations under which the purchase price for each distinct performance obligation is defined in the contract.

These distinct performance obligations may include stand-ready provisions, which are arrangements to provide a customer assurance that they will have access to output from our manufacturing facilities, or monthly reservations of capacity fees.

We consider stand-ready provisions and reservation of capacity fees to be performance obligations satisfied over time.

Revenues related to stand-ready provisions and reservation of capacity fees are recognized on a ratable basis throughout the contract term and billed to the customer on a monthly basis.

As described above, our MSAs with our customers may outline prices for individual products or contract provisions.

MSAs in the our Ecoservices segment may contain provisions whereby raw materials costs are passed-through to the customer per the terms of their contract.

MSAs in our Ecoservices segment may contain provisions whereby raw materials costs are passed-through to the customer per the terms of their contract.

Our exposure to fluctuations in raw materials prices is limited, as the majority of pass-through contract provisions reset based on fluctuations in the underlying raw material price.

6 unchanged sentences

We do not have any significant payment terms as payment is received at, or shortly after, the point of sale.

We may recognize revenue from bill-and-hold arrangements initiated by a customer.

Under these bill-and-hold arrangements, a customer pays for the goods, but does not take physical possession immediately.

We consider satisfaction of performance obligations when we have finished manufacturing the products based on the agreed upon specifications in accordance with the order.

These products are custom made to each customer’s specifications and cannot be made available for use with another customer’s order.

Once the goods have been segregated in a designated space in the warehouse and the customer has been invoiced, title to the goods and risk of loss has transferred to the customer.

The customers have access to their products to inspect and can take possession prior to the scheduled delivery dates.

Goodwill and Intangible Assets

3 unchanged sentences

Goodwill and intangible assets with indefinite lives are not amortized, but are tested for impairment annually or more frequently if events or circumstances exist that would more likely than not reduce the fair value of the reporting unit below its carrying amount.

Table of Con ten ts

Goodwill is tested for impairment at the reporting unit level.

32 unchanged sentences

Estimates based on these assumptions may differ significantly from actual results.

Changes in factors and assumptions used in assessing potential impairments can have a significant impact on the existence and magnitude of impairments, as well as the time in which such impairments are recognized.

Changes in factors and assumptions used in assessing potential impairments

Table of Con ten ts

can have a significant impact on the existence and magnitude of impairments, as well as the time in which such impairments are recognized.

In addition, we continually review our diverse portfolio of assets to ensure they are achieving their greatest potential and are aligned with our growth strategy.

2 unchanged sentences

For further information, see Note 14 to these consolidated financial statements.

Investments in Affiliated Companies

Investments in affiliated companies are accounted for using the equity method of accounting if the investment provides the Company with the ability to exercise significant influence, but not control, over the investee.

Under the equity method of accounting, the investments in equity-method investees are recorded in the consolidated balance sheets as investments in affiliated companies, and the Company’s share of the investees’ earnings or losses, together with other than temporary impairments in value, is recorded as equity in net income from affiliated companies in the consolidated statements of income.

Any differences between the Company’s cost of an equity method investment and the underlying equity in the net assets of the investment, such as fair value step-ups resulting from acquisitions, are accounted for according to their nature and impact the amounts recognized as equity in net income from affiliated companies in the consolidated statements of income.

The Company evaluates its equity method investments for impairment whenever events or changes in circumstances indicate that the carrying amounts of such investments may be impaired.

If a decline in the fair value of an equity method investment is determined to be other than temporary, a loss is recorded in earnings in the current period.

For the purposes of the equity method investment impairment test, we determine the fair value of our investment using a combination of a market approach and an income, or discounted cash flow.

Estimating the fair value of an equity method investment requires various assumptions including the use of projections of future cash flows and discount rates that reflect the risks associated with achieving those cash flows.

The key assumptions used in estimating the fair value are operating margin growth rates, revenue growth rates, selling, general and administrative expenses growth rates, the weighted average cost of capital, the perpetual growth rate, the estimated earnings market multiple, and the estimated control premium.

The market value is estimated using publicly traded comparable company values by applying their most recent annual Adjusted EBITDA multiples to the reporting unit’s Adjusted EBITDA for the trailing twelve months.

The income approach value is estimated using a discounted cash flow approach.

The assumptions about future cash flows and growth rates are based on our assessment of a number of factors including the investee’s recent performance against budget as well as its ability to execute planned future strategic initiatives.

Discount rate assumptions are based on an assessment of the risk inherent in those future cash flows.

Assessment of the potential impairment of investments in affiliate companies is an integral part of our normal ongoing review of operations.

Testing for potential impairment of these assets is significantly dependent on numerous assumptions and reflects management’s best estimates at a particular point in time.

Estimates based on these assumptions may differ significantly from actual results.

In addition, we continually review our diverse portfolio of assets to ensure they are achieving their greatest potential and are aligned with our growth strategy.

Strategic decisions may trigger an assessment of the recoverability of the related assets.

Such an assessment could result in impairment losses.

For further information, see Note 10 to these consolidated financial statements.

We operate within multiple taxing jurisdictions and are subject to tax filing requirements and potential audits within these jurisdictions.

3 unchanged sentences

We use the asset and liability method in accounting for income taxes.

Deferred tax assets and liabilities are recorded for temporary differences between the tax basis of assets and liabilities and their reported amounts in the financial statements, using statutory tax rates in effect for the year in which the differences are expected to reverse.

Table of Con ten ts

the year in which the differences are expected to reverse.

The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the results of operations in the period that includes the enactment date.

17 unchanged sentences

These accrued liabilities represent a provision for taxes that are reasonably expected to be incurred on the basis of available information but which are not certain.

Table of Con ten ts

Stock-Based Compensation

8 unchanged sentences

Prior to the Company’s IPO, the Company issued restricted stock awards and stock options with performance conditions that were based on the occurrence of a defined liquidity event upon which certain investment funds affiliated with CCMP receive proceeds exceeding defined thresholds.

Although achievement of the performance condition is subject to continued service with us, the terms of awards issued with performance conditions stipulate that the performance vesting

condition can be attained for a period of six months following separation from service under certain circumstances, depending on the means of separation from the Company and subject to other factors such as individual separation agreements.

Although achievement of the performance condition is subject to continued service with us, the terms of awards issued with performance conditions stipulate that the performance vesting condition can be attained for a period of six months following separation from service under certain circumstances, depending on the means of separation from the Company and subject to other factors such as individual separation agreements.

The same performance vesting condition for our restricted stock awards also governs the achievement of the performance vesting condition for our stock options.

6 unchanged sentences

No compensation expense has been recognized to-date on any of our restricted stock awards and stock options subject to vesting based on performance conditions, since a liquidity event triggering vesting of the awards has not occurred, nor is it considered probable.

The grant date fair value of restricted stock awards, restricted stock units and performance stock units is based on the value of our common stock as traded on the New York Stock Exchange.

The grant date fair value of restricted stock awards, restricted stock units and performance stock units is based on the value of our common stock as traded on the NYSE.

The grant date fair value of stock option awards is estimated using a Black-Scholes option pricing model.

3 unchanged sentences

See Note 3 to our consolidated financial statements for a discussion of recently issued accounting standards and their effect on us.

Table of Con ten ts

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-K

Item 7. Management’s Discussion and Analysis